Activation of TLR in tumor cells creates a TME that damages the immune system, promotes tumor development, and adversely affects the anti-tumor response in TME, and the NF-κB pathway may partly be responsible for the above unfavorable immune reactions (127). Here, NFKB1 is linked to neoplasm.